Terms: = Leukemia AND RANBP17, ENSG00000204764, 64901, Q9H2T7, FLJ32916
9 results:
1. Genetic and Epigenetic Characterization of a Discordant
Russo A; Viberti C; Mareschi K; Casalone E; Guarrera S; Birolo G; Cazzaniga G; Corral L; Trentin L; Basso G; Fagioli F; Matullo G
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575904
[TBL] [Abstract] [Full Text] [Related]
2. Mapping of 5q35 chromosomal rearrangements within a genomically unstable region.
Buysse K; Crepel A; Menten B; Pattyn F; Antonacci F; Veltman JA; Larsen LA; Tümer Z; de Klein A; van de Laar I; Devriendt K; Mortier G; Speleman F
J Med Genet; 2008 Oct; 45(10):672-8. PubMed ID: 18628311
[TBL] [Abstract] [Full Text] [Related]
3. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).
Su XY; Della-Valle V; Andre-Schmutz I; Lemercier C; Radford-Weiss I; Ballerini P; Lessard M; Lafage-Pochitaloff M; Mugneret F; Berger R; Romana SP; Bernard OA; Penard-Lacronique V
Blood; 2006 Dec; 108(13):4198-201. PubMed ID: 16926283
[TBL] [Abstract] [Full Text] [Related]
4. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia.
Su XY; Busson M; Della Valle V; Ballerini P; Dastugue N; Talmant P; Ferrando AA; Baudry-Bluteau D; Romana S; Berger R; Bernard OA
Genes Chromosomes Cancer; 2004 Nov; 41(3):243-9. PubMed ID: 15334547
[TBL] [Abstract] [Full Text] [Related]
5. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).
Berger R; Dastugue N; Busson M; Van Den Akker J; Pérot C; Ballerini P; Hagemeijer A; Michaux L; Charrin C; Pages MP; Mugneret F; Andrieux J; Talmant P; Hélias C; Mauvieux L; Lafage-Pochitaloff M; Mozziconacci MJ; Cornillet-Lefebvre P; Radford I; Asnafi V; Bilhou-Nabera C; Nguyen Khac F; Léonard C; Speleman F; Poppe B; Bastard C; Taviaux S; Quilichini B; Herens C; Grégoire MJ; Cavé H; Bernard OA;
Leukemia; 2003 Sep; 17(9):1851-7. PubMed ID: 12970786
[TBL] [Abstract] [Full Text] [Related]
6. Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).
MacLeod RA; Nagel S; Kaufmann M; Janssen JW; Drexler HG
Genes Chromosomes Cancer; 2003 May; 37(1):84-91. PubMed ID: 12661009
[TBL] [Abstract] [Full Text] [Related]
7. Disruption of the ranbp17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11).
Hansen-Hagge TE; Schäfer M; Kiyoi H; Morris SW; Whitlock JA; Koch P; Bohlmann I; Mahotka C; Bartram CR; Janssen JW
Leukemia; 2002 Nov; 16(11):2205-12. PubMed ID: 12399963
[TBL] [Abstract] [Full Text] [Related]
8. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.
Bernard OA; Busson-LeConiat M; Ballerini P; Mauchauffé M; Della Valle V; Monni R; Nguyen Khac F; Mercher T; Penard-Lacronique V; Pasturaud P; Gressin L; Heilig R; Daniel MT; Lessard M; Berger R
Leukemia; 2001 Oct; 15(10):1495-504. PubMed ID: 11587205
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a novel putative Ran-binding protein and its close homologue.
Koch P; Bohlmann I; Schäfer M; Hansen-Hagge TE; Kiyoi H; Wilda M; Hameister H; Bartram CR; Janssen JW
Biochem Biophys Res Commun; 2000 Nov; 278(1):241-9. PubMed ID: 11071879
[TBL] [Abstract] [Full Text] [Related]
